-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VhkPxS505BKfynBXC118RRE5gUcTlFgQnu4CHmrwurjqZLtSCf56OGlsTmvf6ZlF AmZWmrWP9XFF4DWpUckQlA== 0001104659-09-058723.txt : 20091013 0001104659-09-058723.hdr.sgml : 20091012 20091013161131 ACCESSION NUMBER: 0001104659-09-058723 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20091013 DATE AS OF CHANGE: 20091013 GROUP MEMBERS: GEORGE R. ROBERTS GROUP MEMBERS: HENRY R. KRAVIS GROUP MEMBERS: KKR 1996 GP LLC GROUP MEMBERS: KKR ASSOCIATES 1996, L.P. GROUP MEMBERS: MEDCATH 1998 LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDCATH CORP CENTRAL INDEX KEY: 0001139463 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 562248952 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62451 FILM NUMBER: 091116975 BUSINESS ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 7047086600 MAIL ADDRESS: STREET 1: 10720 SIKES PLACE SUITE 300 CITY: CHARLOTTE STATE: NC ZIP: 28277 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KKR 1996 FUND L P CENTRAL INDEX KEY: 0001031665 IRS NUMBER: 133900817 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: KOHLBERG KRAVIS ROBERTS & CO STREET 2: 9 WEST 57TH STREET SUITE 4200 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127508300 MAIL ADDRESS: STREET 1: C/O KKR & CO STREET 2: 9 WEST 57TH ST 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13G/A 1 a09-31484_1sc13ga.htm SC 13G/A

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No. 3)*

 

MedCath Corporation

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

58404W 10 9

(CUSIP Number)

October 1, 2009

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

o

Rule 13d-1(c)

x

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No. 58404W 10 9

 

 

1.

Name of Reporting Person
MedCath 1998 LLC

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
1,968,522

 

6.

Shared Voting Power
-0-

 

7.

Sole Dispositive Power
1,968,522

 

8.

Shared Dispositive Power
-0-

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,968,522

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
10.0%

 

 

12.

Type of Reporting Person (See Instructions)
OO

 

2



 

CUSIP No. 58404W 10 9

 

 

1.

Name of Reporting Person
KKR 1996 Fund L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
1,968,522

 

6.

Shared Voting Power
-0-

 

7.

Sole Dispositive Power
1,968,522

 

8.

Shared Dispositive Power
-0-

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,968,522

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
10.0%

 

 

12.

Type of Reporting Person (See Instructions)
PN

 

3



 

CUSIP No. 58404W 10 9

 

 

1.

Name of Reporting Person
KKR Associates 1996, L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
1,968,522

 

6.

Shared Voting Power
-0-

 

7.

Sole Dispositive Power
1,968,522

 

8.

Shared Dispositive Power
-0-

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,968,522

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
10.0%

 

 

12.

Type of Reporting Person (See Instructions)
PN

 

4



 

CUSIP No. 58404W 10 9

 

 

1.

Name of Reporting Person
KKR 1996 GP LLC

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
1,968,522

 

6.

Shared Voting Power
-0-

 

7.

Sole Dispositive Power
1,968,522

 

8.

Shared Dispositive Power
-0-

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,968,522

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
10.0%

 

 

12.

Type of Reporting Person (See Instructions)
OO

 

5



 

 

1.

Name of Reporting Person
Henry R. Kravis

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United States

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
7,500

 

6.

Shared Voting Power
1,968,522

 

7.

Sole Dispositive Power
7,500

 

8.

Shared Dispositive Power
1,968,522

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,976,022

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
10.1%

 

 

12.

Type of Reporting Person (See Instructions)
IN

 

6



 

 

1.

Name of Reporting Person
George R. Roberts

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
United States

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
-
0-

 

6.

Shared Voting Power
1,968,522

 

7.

Sole Dispositive Power
-
0-

 

8.

Shared Dispositive Power
1,968,522

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,968,522

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
10.0%

 

 

12.

Type of Reporting Person (See Instructions)
IN

 

7



 

SCHEDULE 13G

 

This Amendment No. 3 amends and restates Amendment No. 2 to the Schedule 13G of the reporting persons filed with the United States Securities and Exchange Commission on February 14, 2008, with respect to the common stock, $0.01 par value per share, of MedCath Corporation, a Delaware corporation, beneficially owned by the reporting persons.  This amendment is being filed to add Henry R. Kravis and George R. Roberts as additional reporting persons concurrently with filings being made as a result of a structural reorganization of KKR & Co. L.P. and its affiliates (“KKR”) in connection with the combination of the businesses of KKR and KKR Private Equity Investors, L.P.

 

Item 1.

 

(a)

Name of Issuer.
MedCath Corporation

 

(b)

Address of Issuer’s Principal Executive Offices.
10720 Sikes Place, Suite 300

Charlotte, North Carolina 28277

 

Item 2.

 

(a)

Name of Persons Filing.

MedCath 1998 LLC

KKR 1996 Fund L.P.

KKR Associates 1996, L.P.

KKR 1996 GP LLC

Henry R. Kravis

George R. Roberts

 

(b)

Address of Principal Business Office, or, if none, Residence.
The address of the principal business office of MedCath 1998 LLC, KKR 1996 Fund L.P., KKR Associates 1996, L.P., KKR 1996 GP LLC and Henry R. Kravis is:

 

c/o Kohlberg Kravis Roberts & Co. L.P.

9 West 57th Street, Suite 4200

New York, NY 10019

 

The address of the principal business office of George R. Roberts is:

 

c/o Kohlberg Kravis Roberts & Co. L.P.

2800 Sand Hill Road, Suite 200

Menlo Park, California 94025

 

(c)

Citizenship.
See Item 4 of each cover page.

 

(d)

Title of Class of Securities.
Common stock, $0.01 par value per share.

 

(e)

CUSIP Number.
58404W 10 9

 

Item 3.

 

Not applicable.

 

8



 

Item 4.

Ownership.

 

(a)

Amount beneficially owned:   

 

MedCath 1998 LLC holds directly, and has sole voting and dispositive power with respect to 1,968,522 shares of common stock, $0.01 par value per share (the “Common Stock”), of MedCath Corporation.  As the managing member of MedCath 1998 LLC, KKR 1996 Fund L.P. may be deemed to be the beneficial owner of the shares of Common Stock held by MedCath 1998 LLC.  KKR Partners II, L.P. is also a member of MedCath 1998 LLC.  In addition, each of KKR Associates 1996, L.P. (as the sole general partner of KKR 1996 Fund L.P.), KKR 1996 GP LLC (as the sole general partner of KKR Associates 1996, L.P.) and Henry R. Kravis and George R. Roberts (as the managers of KKR 1996 GP LLC) may be deemed to have or share beneficial ownership of the shares of Common Stock held by MedCath 1998 LLC.  Each reporting person disclaims any such beneficial ownership of such shares of Common Stock.

 

In addition to the shares of Common Stock described above, Mr. Kravis may be deemed to beneficially own 7,500 shares of Common Stock in his individual capacity.

 

(b)

Percent of class:   

See Item 11 of each cover page.  The percentages of beneficial ownership are based on 19,641,519 shares of Common Stock outstanding as of August 4, 2009.

 

(c)

Number of shares as to which the person has:

 

 

 

(i)

Sole power to vote or to direct the vote   

See Item 5 of each cover page.

 

 

(ii)

Shared power to vote or to direct the vote    

See Item 6 of each cover page.

 

 

(iii)

Sole power to dispose or to direct the disposition of   

See Item 7 of each cover page.

 

 

(iv)

Shared power to dispose or to direct the disposition of   

See Item 8 of each cover page.

 

Item 5.

Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

See Item 4 above.  To the best knowledge of the Reporting Persons, no one other than the Reporting Persons, the partners, members, affiliates or shareholders of the Reporting Persons and any other persons named in Item 4 has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

 

Item 9.

Notice of Dissolution of Group.

Not applicable.

 

9



 

Item 10.

Certifications.

Not applicable.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

October 13, 2009

MEDCATH 1998 LLC

 

 

 

 

By:

KKR 1996 Fund L.P., managing member

 

 

 

 

By:

KKR Associates 1996, L.P., general partner

 

 

 

 

By:

KKR 1996 GP LLC, general partner

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Member

 

 

 

 

 

 

 

KKR 1996 Fund L.P.

 

 

 

 

By:

KKR Associates 1996, L.P., general partner

 

 

 

 

By:

KKR 1996 GP LLC, general partner

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Member

 

 

 

 

 

 

 

KKR Associates 1996, L.P.

 

 

 

 

By:

KKR 1996 GP LLC, general partner

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Member

 

10



 

 

KKR 1996 GP LLC

 

 

 

 

 

 

By:

/s/ William Janetschek

 

 

Name: William Janetschek

 

 

Title:  Member

 

 

 

 

 

 

 

HENRY R. KRAVIS

 

 

 

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Attorney-in-fact for Henry R. Kravis

 

 

 

 

 

 

 

GEORGE R. ROBERTS

 

 

 

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Attorney-in-fact for George R. Roberts

 

11



 

EXHIBITS

 

Exhibit
Number

 

Title

 

 

 

1

 

Joint Filing Agreement dated October 13, 2009

 

 

 

2

 

Power of Attorney, dated July 31, 2005, given by Henry R. Kravis

 

 

 

3

 

Power of Attorney, dated July 31, 2005, given by George R. Roberts

 

12


EX-99.1 2 a09-31484_1ex99d1.htm EX-99.1

EXHIBIT 1

 

Joint Filing Agreement

 

We, the signatories of the Statement on Schedule 13G to which this Agreement is attached, hereby agree that such statement is, and any amendments thereto filed by any of us will be, filed on behalf of each of us.

 

 

October 13, 2009

MEDCATH 1998 LLC

 

 

 

 

By:

KKR 1996 Fund L.P., managing member

 

 

 

 

By:

KKR Associates 1996, L.P., general partner

 

 

 

 

By:

KKR 1996 GP LLC, general partner

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Member

 

 

 

 

 

 

 

KKR 1996 Fund L.P.

 

 

 

 

By:

KKR Associates 1996, L.P., general partner

 

 

 

 

By:

KKR 1996 GP LLC, general partner

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Member

 

 

 

 

 

 

 

KKR Associates 1996, L.P.

 

 

 

 

By:

KKR 1996 GP LLC, general partner

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Member

 

1



 

 

KKR 1996 GP LLC

 

 

 

 

 

 

By:

/s/ William Janetschek

 

 

Name: William Janetschek

 

 

Title: Member

 

 

 

 

 

 

 

HENRY R. KRAVIS

 

 

 

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Attorney-in-fact for Henry R. Kravis

 

 

 

 

 

 

 

GEORGE R. ROBERTS

 

 

 

 

 

 

 

By:

/s/ William Janetschek

 

 

Name:  William Janetschek

 

 

Title:  Attorney-in-fact for George R. Roberts

 

2


EX-99.2 3 a09-31484_1ex99d2.htm EX-99.2

Exhibit 2

 

POWER OF ATTORNEY

 

Know all men by these presents that Henry R. Kravis does hereby make, constitute and appoint William J. Janetschek and Richard J. Kreider, or either one of them, as a true and lawful attorney-in-fact of the undersigned with full powers of substitution and revocation, for and in the name, place and stead of the undersigned (both in the undersigned’s individual capacity and as a member of any limited liability company or as a partner of any partnership for which the undersigned is otherwise authorized to sign), to execute and deliver such forms as may be required to be filed from time to time with the Securities and Exchange Commission with respect to:  (i) Sections 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended (the “Act”), including without limitation, Schedule 13D, Schedule 13G, statements on Form 3, Form 4 and Form 5 and (ii) in connection with any applications for EDGAR access codes, including without limitation the Form ID.

 

 

/s/ Henry R. Kravis

 

Name: Henry R. Kravis

 

 

 

 

Date: July 31, 2005

 

 


EX-99.3 4 a09-31484_1ex99d3.htm EX-99.3

Exhibit 3

 

POWER OF ATTORNEY

 

Know all men by these presents that George R. Roberts does hereby make, constitute and appoint William J. Janetschek and Richard J. Kreider, or either one of them, as a true and lawful attorney-in-fact of the undersigned with full powers of substitution and revocation, for and in the name, place and stead of the undersigned (both in the undersigned’s individual capacity and as a member of any limited liability company or as a partner of any partnership for which the undersigned is otherwise authorized to sign), to execute and deliver such forms as may be required to be filed from time to time with the Securities and Exchange Commission with respect to:  (i) Sections 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended (the “Act”), including without limitation, Schedule 13D, Schedule 13G, statements on Form 3, Form 4 and Form 5 and (ii) in connection with any applications for EDGAR access codes, including without limitation the Form ID.

 

 

/s/ George R. Roberts

 

Name: George R. Roberts

 

 

 

 

Date:  July 31, 2005

 

 


-----END PRIVACY-ENHANCED MESSAGE-----